Versus Systems Inc.
For the period ended Dec 31, 2025. Filed Apr 15, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 15, 2026
VS$0.84+3.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Balance Sheets
| December 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| ($) | ($) | |
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $527,388 | $3,065,914 |
| Accounts Receivable | 836,000 | - |
| Prepaid expenses | 88,674 | 469,646 |
| Total current assets | 1,452,062 | 3,535,560 |
| Intangible asset | 609,000 | - |
| Total assets | $2,061,062 | $3,535,560 |
| LIABILITIES AND EQUITY | ||
| Current liabilities | ||
| Accounts payable and accrued liabilities | $142,759 | $26,288 |
| Total current liabilities | 142,759 | 26,288 |
| Non-current liabilities | ||
| Total liabilities | 142,759 | 26,288 |
| Stockholders’ equity | ||
| Share capital | ||
| Preferred stock, no par value. 100,000,000 authorized shares; no shares issued or outstanding, respectively | - | - |
| Common stock and additional paid in capital, no par value. 200,000,000 authorized shares; 4,901,677 and 4,901,677 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 151,017,446 | 150,587,018 |
| Accumulated other comprehensive income | 441,995 | 318,659 |
| Deficit | (141,268,519) | (139,476,353) |
| Total Versus Systems, Inc. stockholders’ equity | 10,190,922 | 11,429,324 |
| Non-controlling interest | (8,272,619) | (7,920,052) |
| Total stockholders’ equity | 1,918,303 | 3,509,272 |
| Total liabilities, noncontrolling interest and stockholders’ equity | $2,061,062 | $3,535,560 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.